MedPath

A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.

Not Applicable
Completed
Conditions
HIV Infections
Registration Number
NCT00000855
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to examine the safety and tolerability of ZDV when given to premature infants born to HIV-positive women to prevent HIV infection.

ZDV has been used successfully to prevent the transmission of HIV from mother to child during pregnancy and birth. However, ZDV has been given to very few premature babies, and the best dose to use has not yet been determined.

Detailed Description

In the preliminary group of premature infants, those receiving q 6h dosing had an average trough concentration of 7.3 uM (18%). However, the premature infants in the preliminary pharmacokinetic study did not have long term follow-up to assess toxicity. Due to the potential for altered ZDV pharmacokinetics and increased toxicity in this population, an evaluation of ZDV pharmacokinetics in premature infants is proposed.

Premature infants less than or equal to 34 weeks gestational age at birth and begun on ZDV by their clinical caregivers will be entered into the protocol within the first 5 days of life. Upon entry, ZDV will be administered every 12 hours intravenously or orally. The study will require 9 serum samples for ZDV assay collected over 30 days, some additional clinical laboratory tests collected over 12 weeks, collection of 3 spot urine samples, and collection of routine clinical data.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (36)

Univ of Alabama at Birmingham - Pediatric

🇺🇸

Birmingham, Alabama, United States

Phoenix Childrens Hosp

🇺🇸

Phoenix, Arizona, United States

UCSD Med Ctr / Pediatrics / Clinical Sciences

🇺🇸

La Jolla, California, United States

Los Angeles County - USC Med Ctr

🇺🇸

Los Angeles, California, United States

UCLA Med Ctr / Pediatric

🇺🇸

Los Angeles, California, United States

Harbor - UCLA Med Ctr / UCLA School of Medicine

🇺🇸

Los Angeles, California, United States

Children's Hosp of Oakland

🇺🇸

Oakland, California, United States

San Francisco Gen Hosp

🇺🇸

San Francisco, California, United States

UCSF / Moffitt Hosp - Pediatric

🇺🇸

San Francisco, California, United States

Univ of Florida Gainesville

🇺🇸

Gainesville, Florida, United States

Scroll for more (26 remaining)
Univ of Alabama at Birmingham - Pediatric
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.